FDA Clearance Tracker · P010012-S383
ACUITY SPIRAL LEADS
Last checked: Nov 20, 2026Latest source record: Mar 19, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Mar 19, 2015
Approved
Time to decision
87 days
Received Dec 22, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010012-S383
- Device name
- ACUITY SPIRAL LEADS
- Applicant
- Boston Scientific Corp
- Applicant location
- St Paul, MN
- Received
- Dec 22, 2014
- Decided
- Mar 19, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P010012
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR CHANGING FROM OXYFUME TO 100% ETHYLENE OXIDE STERILIZATION AND UPDATED LABELING.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.